Pharmacie by Medi-Market Group - Schoten
0566.901.652 · rovalta.com · 28/09/2026
NORMAL SITUATION
Pharmacie by Medi-Market Group - Schoten
Company — Normal situation.
Strike-off: 25 juin 2026
Financial year 2025 · Closed on 31/12/2025
Net result87,8 k €-3,4 %over 1 year
Gross margin110,3 k €+3,1 %over 1 year
Equity1,9 M €+4,9 %over 1 year
Workforce0,0 ETP
Overview
Identity
Source · BCE/KBOPharmacie by Medi-Market Group - Schoten is a Public limited company incorporated in 2014.
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0566.901.652
- Incorporation
- 17/10/2014
- Legal form
- Public limited company
- Contributed capital
- 365 000,00 €
- Latest accounts
- 31/12/2025
- Average workforce
- 0,0 ETP
Joint committees (1)
- 313
Signals
ProfitableSolid equityGood liquidityPositive cashflowPositive EBITDA
Financials
Source · NBB, 11 filingsTrend over 9 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | 110,3 k € | +3.1% | 106,9 k € | +1.0% | 105,9 k € | -15.6% | 125,4 k € | +26.1% | 99,4 k € |
| EBITDA | 109 k € | +3.0% | 105,9 k € | +0.9% | 104,9 k € | -15.5% | 124,1 k € | +27.4% | 97,5 k € |
| Operating result | 75,1 k € | +4.8% | 71,7 k € | +3.4% | 69,3 k € | -21.5% | 88,3 k € | +63.1% | 54,1 k € |
| Net result | 87,8 k € | -3.4% | 90,9 k € | +5.7% | 86 k € | +17.2% | 73,4 k € | +58.3% | 46,4 k € |
| Balance sheet | |||||||||
| Equity | 1,9 M € | +4.9% | 1,8 M € | +5.4% | 1,7 M € | +5.4% | 1,6 M € | +4.8% | 1,5 M € |
| Total assets | 2 M € | +5.4% | 1,9 M € | +4.0% | 1,9 M € | +7.7% | 1,7 M € | -6.3% | 1,9 M € |
| Cash | – | – | – | – | 0 € | ||||
| Debts | 182,3 k € | +10.3% | 165,2 k € | -8.9% | 181,4 k € | +36.1% | 133,3 k € | -58.8% | 323,9 k € |
| Other | |||||||||
| Workforce | 0,0 ETP | – | – | 0,0 ETP | 0,0 ETP | ||||
Board of directors
Source · NBB, accounts to 31/12/20251 active · 1 ended
Active mandates
| Director | Mandates in this company | Period | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
| Director17/10/2014 → 29/06/2026 |
Ended mandates
| Director | Mandates in this company | Period | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
Yvan Verougstraete | Managing director17/10/2014 → 30/12/2020 |
Financials
Full financial information
Source · NBB| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 01/07/2026 | 02/07/2025 | 11/07/2024 | 29/08/2023 | 30/03/2023 | 28/03/2022 |
| General meeting | 29/06/2026 | 27/06/2025 | 01/07/2024 | 25/08/2023 | 30/03/2023 | 28/03/2022 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for freeAnnual accounts filings
Source · NBB, 11 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Abridged model | 31/12/2025 | 29/06/2026 | 01/07/2026 | French | |
| Abridged model | 31/12/2024 | 27/06/2025 | 02/07/2025 | French | |
| Abridged model | 31/12/2023 | 01/07/2024 | 11/07/2024 | French | |
| Abridged model | 31/12/2022 | 25/08/2023 | 29/08/2023 | French | |
| Abridged model | 31/12/2021 | 30/03/2023 | 30/03/2023 | French | |
| Abridged model | 31/12/2020 | 28/03/2022 | 28/03/2022 | French | |
| Abridged model | 31/12/2019 | 18/12/2020 | 18/12/2020 | French | |
| Abridged model | 31/12/2018 | 17/07/2019 | 23/07/2019 | French | |
| Abridged model | 31/12/2017 | 29/06/2018 | 03/07/2018 | French | |
| Abridged model | 31/12/2016 | 15/06/2017 | 14/07/2017 | French | |
| Full model | 31/12/2015 | 16/06/2016 | 06/07/2016 | French |
Valuation
Indicative valuation
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Disclaimer
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/20251 active · 1 ended
Active mandates
| Director | Mandates in this company | Period | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
| Director17/10/2014 → 29/06/2026 |
Ended mandates
| Director | Mandates in this company | Period | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
Yvan Verougstraete | Managing director17/10/2014 → 30/12/2020 |
Ownership and network
Looking for more information about this company?
Try for freePublications
Belgian Official Gazette publications
Source · Belgian Official Gazette- Restructuring02/07/2026ASSEMBLEE GENERALE EXTRAORDINAIRE - Fusion par absorption -
- Restructuring07/05/2026Projet de fusion - Pouvoirs
- Other09/09/2025Renouvellement du mandat du commisaire - Pouvoirs
- Mandates06/02/2023DEMISSIONS, NOMINATIONS
- Mandates05/08/2021DEMISSIONS, NOMINATIONS
- Mandates20/01/2021ONTSLAGEN - BENOEMINGEN - STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, )
- Mandates07/02/2020DEMISSIONS, NOMINATIONS
- Other28/11/2018BENAMING - STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, )
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
Source · CBE, NBB annual accountsYear
Identity
Incorporation
Name
Registered office
Annual accounts
Filings9 filings
Mandates
Medi-Market Group
Yvan Verougstraete
2014201520162017201820192020202120222023202420252026
Pharmacie by Medi-Market Group - SchotenPharmaClic Antwerpen - Schoten
Avenue Cicéron 7, 1140 Evere
Director
Managing director
CurrentPlanned, not yet servedEndedAccounts filedToday
Registered offices
Source · NBB annual accounts, CBE| Registered address | Period | Source |
|---|---|---|
| Avenue Cicéron 7, 1140 Evere | CBE until 25/06/2026 | CBE |
| Avenue Cicéron 7, 1140 Evere | accounts 2021 → 2025 | Accounts 2025 · 2026-00250160 |
Company names
Source · NBB annual accounts, CBE| Name | Period | Source |
|---|---|---|
| Pharmacie by Medi-Market Group - Schoten | CBE until 25/06/2026 | CBE |
| Pharmacie by Medi-Market Group - Schoten | accounts 2018 → 2025 | Accounts 2025 · 2026-00250160 |
| PharmaClic Antwerpen - Schoten | accounts 2015 → 2017 | Accounts 2017 · 2018-28600304 |
Events
- 2025Annual accounts 202587,8 k €↓
- 2024Annual accounts 202490,9 k €↑
- 2023Annual accounts 202386 k €↑
- 2022Annual accounts 202273,4 k €↑
- 2021Annual accounts 202146,4 k €↓
- 2018Annual accounts 201874,1 k €↑
- 2018Name changePharmacie by Medi-Market Group - Schoten
- 2017Annual accounts 201767,1 k €↑
- 2016Annual accounts 2016-42,5 k €↓
- 2015Annual accounts 2015-30,1 k €
- 17/10/2014IncorporationPublic limited company